Index
1 Market Overview of Preimplantation Genetics Diagnosis (PGD)
1.1 Preimplantation Genetics Diagnosis (PGD) Market Overview
1.1.1 Preimplantation Genetics Diagnosis (PGD) Product Scope
1.1.2 Preimplantation Genetics Diagnosis (PGD) Market Status and Outlook
1.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2018-2029)
1.4 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Region (2018-2023)
1.5 Global Preimplantation Genetics Diagnosis (PGD) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.4 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
1.6.5 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size (2018-2029)
2 Preimplantation Genetics Diagnosis (PGD) Market by Type
2.1 Introduction
2.1.1 Gender Selection
2.1.2 Chromosomal Abnormalities
2.1.3 Single Gene Disorders
2.1.4 HLA Typing
2.1.5 Aneuploidy
2.1.6 X-Linked Diseases
2.1.7 Others
2.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2018-2023)
2.2.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Type (2018-2029)
3 Preimplantation Genetics Diagnosis (PGD) Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Application (2018-2023)
3.2.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Breakdown by Application (2018-2029)
4 Preimplantation Genetics Diagnosis (PGD) Competition Analysis by Players
4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2022)
4.3 Date of Key Players Enter into Preimplantation Genetics Diagnosis (PGD) Market
4.4 Global Top Players Preimplantation Genetics Diagnosis (PGD) Headquarters and Area Served
4.5 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
4.6 Competitive Status
4.6.1 Preimplantation Genetics Diagnosis (PGD) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.1.4 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Natera, Inc
5.2.1 Natera, Inc Profile
5.2.2 Natera, Inc Main Business
5.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.2.4 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.2.5 Natera, Inc Recent Developments
5.3 PerkinElmer
5.3.1 PerkinElmer Profile
5.3.2 PerkinElmer Main Business
5.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.3.4 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.3.5 Illumina Recent Developments
5.4 Illumina
5.4.1 Illumina Profile
5.4.2 Illumina Main Business
5.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.4.4 Illumina Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.4.5 Illumina Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 Laboratory Corporation of America Holdings
5.7.1 Laboratory Corporation of America Holdings Profile
5.7.2 Laboratory Corporation of America Holdings Main Business
5.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.7.4 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.7.5 Laboratory Corporation of America Holdings Recent Developments
5.8 Agilent Technologies
5.8.1 Agilent Technologies Profile
5.8.2 Agilent Technologies Main Business
5.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.8.4 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.8.5 Agilent Technologies Recent Developments
5.9 Quest Diagnostics Incorporated
5.9.1 Quest Diagnostics Incorporated Profile
5.9.2 Quest Diagnostics Incorporated Main Business
5.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.9.4 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.9.5 Quest Diagnostics Incorporated Recent Developments
5.10 Cooper Surgical
5.10.1 Cooper Surgical Profile
5.10.2 Cooper Surgical Main Business
5.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.10.4 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.10.5 Cooper Surgical Recent Developments
5.11 Beijing Genomics Institute (BGI)
5.11.1 Beijing Genomics Institute (BGI) Profile
5.11.2 Beijing Genomics Institute (BGI) Main Business
5.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.11.4 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.11.5 Beijing Genomics Institute (BGI) Recent Developments
5.12 Genea Limited
5.12.1 Genea Limited Profile
5.12.2 Genea Limited Main Business
5.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.12.4 Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2018-2023)
5.12.5 Genea Limited Recent Developments
6 North America
6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Preimplantation Genetics Diagnosis (PGD) Market Dynamics
11.1 Preimplantation Genetics Diagnosis (PGD) Industry Trends
11.2 Preimplantation Genetics Diagnosis (PGD) Market Drivers
11.3 Preimplantation Genetics Diagnosis (PGD) Market Challenges
11.4 Preimplantation Genetics Diagnosis (PGD) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List